DEF 14A

Company

Forte Biosciences, Inc.

Filed

December 31, 2024

Period of Report

January 24, 2025

Accession Number

0001193125-24-287177

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →